> A senior clinician at the National Institutes of Health, Ranganath Muniyappa, requested access to the drug for the unnamed patient in April. Muniyappa cited a diagnosis of
refractory obesity with obstructive sleep apnea and pulmonary hypertension, a potentially life-threatening disease characterized by high blood pressure in the lungs.* The request reportedly drew the attention of top health officials, which STAT noted was indicative of the patient’s influence.https://www.statnews.com/2026/06/23/eli-lilly-unusual-weight...